MannKind to Present at Bank of America Merrill Lynch 2014 Health Care
VALENCIA, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation
(Nasdaq:MNKD), focused on discovering, developing and commercializing
treatments for diabetes, announced today that it will present at the Bank of
America Merrill Lynch 2014 Health Care Conference on Wednesday, May 14, 2014
at 8:40 am Pacific Time at the Encore at the Wynn Hotel in Las Vegas, Nevada.
Interested parties can access a link to the live webcast of the presentations
from the News & Events section of the Company's website at
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and
commercialization of therapeutic products for patients with diseases such as
diabetes. Its lead product candidate, AFREZZA^®, is under review by the FDA.
MannKind regularly posts copies of its press releases as well as additional
information about MannKind on its website www.mannkindcorp.com. Interested
persons can subscribe on the website to e-mail alerts that are sent
automatically when MannKind issues press releases, files its reports with the
Securities and Exchange Commission or posts certain other information to the
CONTACT: Company Contact:
Matthew J. Pfeffer
Corporate Vice President and
Chief Financial Officer
MannKind Corporation Logo
Press spacebar to pause and continue. Press esc to stop.